Piper Sandler and Morgan Stanley Highlight Amgen (AMGN) on Pipeline Strength and Obesity Drug Potential

Piper Sandler and Morgan Stanley Highlight Amgen (AMGN) on Pipeline Strength and Obesity Drug Potential  Insider Monkey

Summary aggregated from Insider Monkey's public RSS feed. The full reporting belongs to Insider Monkey — please read it on their site.